[PDF] Top 20 Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate resistant prostate cancer patients

... 24 patients with bone scan/CT scan evidence of one or more skeletal metastases enrolled in the study, nine had no CTCs and therefore did not undergo bone ...and tumor characteristics of the 15 ... See full document

... protein analysis in CTCs has demonstrated that interrogation of AR ex- pression and subcellular localization may have clinical ...quantitative analysis of AR expression and nu- clear localization has ... See full document

... some patients with ARV7-positive liquid biopsies (CTCs or RNA from whole blood) might still derive benefit from enzalutamide or abiraterone therapy [ 19 ...mCRPC patients [ 20 , 21 ...ARV7 ... See full document

... patient bone metastasis, normal patient bone marrow and guided the experiment design and interpretation in terms of clinical insight and relevance to bone metastatic cancer, ... See full document

... mCRPC patients is consistent with substantial evidence supporting their existence and clinical ...CK expression, have been identified by multiple platforms using both cell lines and patient samples ...These ... See full document

... their expression between ...clustering analysis of all 98 patients from the primary set with available QC mRNA data (Figure ...clustering analysis revealed two main clusters, cluster 1 ... See full document

... Primary tumor tissue may be poorly representative of a patient’s metastatic disease which can arise several years after diagnosis and various therapeutic ...throughput analysis are currently ... See full document

... Abstract Prostate cancer is the most frequent noncutaneous cancer occurring in ...localized prostate cancer have a high 10-year survival rate, and many can be ...with metastatic ... See full document

... Statistical Analysis Patient characteristics were compared between those with < 5 CTCs and those with ≥ 5 CTCs by means of chi-square tests for categorical variables and the Mann–Whitney U test for continuous ... See full document

... able from late disease stages and animal models; further, although examination of tissue can provide some signaling pathway information, this mode of studying PCa has lim- ...and analysis of mCRPC CTCs, may ... See full document

... able from late disease stages and animal models; further, although examination of tissue can provide some signaling pathway information, this mode of studying PCa has lim- ...and analysis of mCRPC CTCs, may ... See full document

... WES from CTCs recovered from one vial of ...recovered cells, enriched with CTCs, were deposited into dense arrays of subnanoliter wells and imaged by automated epifluorescence imaging ...of ... See full document

... of patients with metastatic disease turned out to be very rare, and range from 0 to 10000 CTCs per mL of whole blood ...other cells present in blood is shown in Figure ...and prostate ... See full document

... for patients with CRPC but unfortunately only modest research has been reported so far on this ...in patients on ipilimumab, although they are not necessarily predictive of treatment ...of tumor by ... See full document

... MMP9 gene expression. Although the described gene signature did not increase the prognostic significance of CTCs enumeration alone, it adds prognostic ability when it was used in combination with ... See full document

... of circulating tumor cells (CTCs) in peripheral blood correlates with clinical outcome in castration-resistant prostate cancer ...blood from 43 metastatic CRPC ... See full document

... patients with metastatic castration-resistant prostate cancer: results from the University of Washington Rapid Autopsy ...J Bone Miner Res 2013, ...enrichment-free ... See full document

... individual patients with CRPC. As the incidence of prostate cancer is disproportionately high in elderly men, consideration should be given to life expectancy issues, functional sta- tus, and the ... See full document

... anti- cancer regimens in mCRPC patients, overall survival is an important endpoint, requiring reliable prognostic criteria to adjust for the heterogeneity of the ...results from new imaging ... See full document

... ETS gene fusions in PCa, on which Scott ...honoraria from, Ventana/Roche, Astellas, Medivation and Abbvie, and is a co-founder of Strata ...of Cancer Research that has developed abiraterone and ... See full document